Lack of inducible nitric oxide synthase prevents lipid-induced skeletal muscle insulin resistance without attenuating cytokine level

Journal of Pharmacological Sciences

Volumn 117, Issue 2, 2011, Pages 77-86

  Cha, Hye Na ^a   Song, Seung Eun ^a   Kim, Yong Woon ^a   Kim, Jong Yeon ^a   Won, Kyu Chang ^a   Park, So Young ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Cytokine; Inducible nitric oxide synthase (iNOS); Insulin resistance; Lipid; Skeletal muscle

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; INSULIN RESISTANCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 80054731672     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11093FP     Document Type: Article

References (39)

1. Petersen KF, Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol. 2002; 90:11G-18G. (Pubitemid 35266676)
2. Eckardt K, Sell H, Eckel J. Novel aspects of adipocyte-induced skeletal muscle insulin resistance. Arch Physiol Biochem. 2008; 114:287-298.
3. Paolisso G, Gambardella A, Tagliamonte MR, Saccomanno F, Salvatore T, Gualdiero P, et al. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J Clin Endocrinol Metab. 1996;81:4244-4248. (Pubitemid 26412024)
4. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes. 1997;46:1768-1774. (Pubitemid 27456409)
5. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes. 2001;50:2579-2584. (Pubitemid 33642777)
6. Krebs M, Roden M. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes Obes Metab. 2005;7:621-632. (Pubitemid 41601067)
7. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97:2859-2865. (Pubitemid 26197099)
8. Mungrue IN, Bredt DS, Stewart DJ, Husain M. From molecules to mammals: what's NOS got to do with it? Acta Physiol Scand. 2003;179:123-135. (Pubitemid 37249246)
9. Lira VA, Soltow QA, Long JH, Betters JL, Sellman JE, Criswell DS. Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. Am J Physiol. 2007;293: E1062-E1068. (Pubitemid 47535838)
10. Behr-Roussel D, Rupin A, Simonet S, Bonhomme E, Coumailleau S, Cordi A, et al. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation. 2000;102:1033-1038. (Pubitemid 30656011)
11. Shimabukuro M, Ohneda M, Lee Y, Unger RH. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest. 1997; 100:290-295. (Pubitemid 27349075)
12. Takahashi Y, Nakano T, Wakabayashi I. Increased induction of inducible nitric oxide synthase expression in aortae of type 2 diabetes rats. J Pharmacol Sci. 2008;107:190-200. (Pubitemid 351931020)
13. Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med. 2001;7:1138-1143. (Pubitemid 33010023)
14. Sung HK, Kim YW, Choi SJ, Kim JY, Jeune KH, Won KC, et al. COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice. Am J Physiol. 2009;297:E402-E409.
15. Park SY, Cho YR, Kim HJ, Higashimori T, Danton C, Lee MK, et al. Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes. 2005;54:3530-3540. (Pubitemid 43334346)
16. Cha HN, Kim YW, Kim JY, Kim YD, Song IH, Min KN, et al. Lack of inducible nitric oxide synthase does not prevent aging-associated insulin resistance. Exp Gerontol. 2010;45:711-718.
17. Yano S, Morino-Koga S, Kondo T, Suico MA, Koga T, Shimauchi Y, et al. Glucose uptake in rat skeletal muscle L6 cells is increased by low-intensity electrical current through the activation of the phosphatidylinositol-3-OH kinase (PI-3K) / Akt pathway. J Pharmacol Sci. 2011;115:94-98.
18. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599-622. (Pubitemid 35191625)
19. Senn JJ. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem. 2006;281:26865-26875. (Pubitemid 44401715)
20. Kim BS, Cha HN, Kim YW, Kim JY, Dan JM, Park SY. Inhibition of lipid infusion-induced skeletal muscle insulin resistance by cotreatment with tempol and glutathione in mice. J Pharmacol Sci. 2009;110:370-380.
21. Ouvina SM, La Greca RD, Zanaro NL, Palmer L, Sassetti B. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res. 2001; 102:107-114. (Pubitemid 32373219)
22. Torres SH, De Sanctis JB, de L Briceno M, Hernandez N, Finol HJ. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol. 2004;181:419-427. (Pubitemid 38868192)
23. Tsuchiya K, Sakai H, Suzuki N, Iwashima F, Yoshimoto T, Shichiri M, et al. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice. Endocrinology. 2007;148:4548-4556. (Pubitemid 47481508)
24. Charbonneau A, Marette A. Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes. 2010;59:861-871.
25. Sass G, Koerber K, Bang R, Guehring H, Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest. 2001;107:439-447. (Pubitemid 32167990)
26. Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, Kantengwa S, et al. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J Hepatol. 2004;41:773-781. (Pubitemid 39434307)
27. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes. 2005; 54:2939-2945. (Pubitemid 41401090)
28. Lang CH. Beta-adrenergic blockade attenuates insulin resistance induced by tumor necrosis factor. Am J Physiol. 1993;264: R984-R991. (Pubitemid 23152583)
29. del Aguila LF, Claffey KP, Kirwan JP. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol. 1999;276:E849-E855. (Pubitemid 29249603)
30. Nolte LA, Hansen PA, Chen MM, Schluter JM, Gulve EA, Holloszy JO. Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle. Diabetes. 1998;47:721-726. (Pubitemid 28201800)
31. Krogh-Madsen R, Plomgaard P, Moller K, Mittendorfer B, Pedersen BK. Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans. Am J Physiol. 2006;291:E108-E114. (Pubitemid 44035315)
32. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271: C1424-C1437.
33. Shen HM, Liu ZG. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med. 2006;40:928-939.
34. Miyoshi T, Li Y, Shih DM, Wang X, Laubach VE, Matsumoto AH, et al. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Life Sci. 2006;79:525-531.
35. Rudnick J, Puttmann B, Tesch PA, Alkner B, Schoser BG, Salanova M, et al. Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest. FASEB J. 2004; 18:1228-1230. (Pubitemid 39561559)
36. Bradley SJ, Kingwell BA, Canny BJ, McConell GK. Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training. Metabolism. 2007;56:1405-1411. (Pubitemid 47407755)
37. Turini P, Thalmann S, Jayet PY, Cook S, Mathieu C, Burcelin R, et al. Insulin resistance in mice lacking neuronal nitric oxide synthase is related to an alpha-adrenergic mechanism. Swiss Med Wkly. 2007;137:700-704.
38. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes. 2000;49:684-687. (Pubitemid 30339980)
39. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001; 104:342-345. (Pubitemid 32666958)